Bioethics News

Dealmakers Behind Soaring Drug Prices Hit the Jackpot

Dealmakers have always flipped companies. Lately, they’ve been flipping something else: aging pharmaceuticals

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.